The estimated Net Worth of De Solidarite Des Travaille... is at least $7.59 Million dollars as of 28 July 2020. De Travaille owns over 519,863 units of Milestone Pharmaceuticals Inc stock worth over $3,269,634 and over the last 5 years De sold MIST stock worth over $4,320,062.
Sign up
De Travaille MIST stock SEC Form 4 insiders trading
De has made over 2 trades of the Milestone Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently De sold 519,863 units of MIST stock worth $4,320,062 on 28 July 2020.
The largest trade De's ever made was selling 519,863 units of Milestone Pharmaceuticals Inc stock on 28 July 2020 worth over $4,320,062. On average, De trades about 476,598 units every 221 days since 2019. As of 28 July 2020 De still owns at least 2,254,920 units of Milestone Pharmaceuticals Inc stock.
You can see the complete history of De Travaille stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's De Travaille's mailing address?
De's mailing address filed with the SEC is 545 CREMAZIE EAST BOULEVARD, #200, , MONTREAL, A8, H2M 2W4.
Insiders trading at Milestone Pharmaceuticals Inc
Over the last 5 years, insiders at Milestone Pharmaceuticals Inc have traded over $8,160,062 worth of Milestone Pharmaceuticals Inc stock and bought 3,714,592 units worth $46,347,389 . The most active insiders traders include Holdings A/S Novo, Investments, Lpwong Roderic..., and Joseph C Papa. On average, Milestone Pharmaceuticals Inc executives and independent directors trade stock every 57 days with the average trade being worth of $438,690. The most recent stock trade was executed by David Bharucha on 1 December 2022, trading 10,000 units of MIST stock currently worth $47,400.
What does Milestone Pharmaceuticals Inc do?
milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.
What does Milestone Pharmaceuticals Inc's logo look like?
Complete history of De Travaille stock trades at Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc executives and stock owners
Milestone Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Joseph G. Oliveto,
CEO, Pres & Director -
Amit Hasija,
CFO & Exec. VP of Corp. Devel. -
Dr. Francis Plat,
Chief Medical Officer -
Lorenz Muller,
Chief Commercial Officer -
Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.,
Chief Medical Advisor & Member of the Scientific Advisory Board -
Jeff Nelson,
Chief Operating Officer -
Dr. Philippe Douville,
Founder, Strategic Advisor & Member of Scientific Advisory Board -
Richard C Pasternak,
Director -
Debra K. Liebert,
Director -
Paul F Truex,
Director -
Joseph C Papa,
-
Amit Hasija,
CFO & EVP of Corp. Development -
Seth H. Z. Fischer,
-
Timothy Maness,
Chief Accounting Officer -
Philippe Douville,
Chief Scientific Officer -
De Solidarite Des Travaille...,
10% owner -
Holdings A/S Novo,
10% owner -
Investments, Lpwong Roderic...,
-
Capital Inc. Bdc,
10% owner -
Francis Plat,
Chief Medical Officer -
Joseph Oliveto,
President and CEO -
Lorenz Muller,
Chief Commercial Officer -
Paul R Edick,
Director -
Michael John Tomsicek,
-
Stuart Duty,
-
David Bharucha,
Chief Medical Officer -
Jeffrey Edward Nelson,
Chief Operating Officer -
Lisa M. Giles,
-
Robert James Wills,